Novartis Ag (NVSEF) Gross Margin (QoQ) (2009 - 2023)

Novartis Ag (NVSEF) Gross Margin (QoQ) (2009 - 2023) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -154.31 Mn
Mar 31, 2023 153.60 Mn
Dec 31, 2022 720,115.00
Sep 30, 2022 -7,261.00
Jun 30, 2022 5,980.00
Mar 31, 2022 1,317.00
Dec 31, 2021 -924.00
Sep 30, 2021 -6,311.00
Jun 30, 2021 -498.21 Mn
Mar 31, 2021 497.51 Mn
Dec 31, 2020 709,120.00
Sep 30, 2020 -6,464.00
Jun 30, 2020 -185.00
Jun 30, 2019 6,432.00
Mar 31, 2019 -37,659.00
Dec 31, 2018 17,023.00
Sep 30, 2018 14,708.00
Jun 30, 2018 6,066.00
Mar 31, 2018 479.00
Dec 31, 2017 -43,006.00